The Pharmacodynamic (PD) Biomarkers report features an extensive regional analysis, identifying market penetration levels across major geographic areas. It highlights regional growth trends and opport
Additional vital signs taken during the open-label period, including pulse, blood pressure, and mean arterial pressure Study Description A Phase II, randomized, double-blind, withdrawal to placebo stu
Ceftazidime-avibactam (CAZ-AVI), a novel antibiotic, is effective in treating infections caused by carbapenem-resistant Gram-negative bacteria. However, in patients receiving continuous renal replacem
